ALS market across 8MM set to reach $1.28 bn in 2029: GlobalData GlobalData Jun 13, 2024 The prevalence of ALS is increasing at a steady rate, in line with population growth in the 8MM, at an AGR of 0.79 per cent
Myasthenia gravis market to generate sales of $6.7 bn across 7MM by 2032: GlobalData EP News Bureau Nov 9, 2023 GlobalData identified the influx of several new disease-modifying therapies (DMTs) within the past two years as the main driver of…
Parkinson’s unmet needs present significant opportunity for new entrants: GlobalData EP News Bureau May 25, 2023 The need for disease-modifying therapies is one of the highest unmet needs and if a curative or disease-modifying agent was…
